Back to results
US 12,753,231 B2Granted
NKG2A-targeting antibody and use thereof
AssigneeBioheng Therapeutics Limited
InventorsYali Zhou, Gong Chen, Xiaoyan Jiang, Tingting Guo, Jiangtao Ren, Xiaohong He, Yanbin Wang, Lu Han
Life of this patent
Estimating the term…
Abstract
Provided are an NKG2A-targeting antibody, and a multispecific antibody, a chimeric receptor, an antibody conjugate, a pharmaceutical composition and a kit which comprise same, and the use thereof in the diagnosis/treatment/prevention of diseases associated with NKG2A expression.
Claims5
A NKG2A-targeting antibody, comprising a light chain variable region and a heavy chain variable region, wherein the light chain variable region has an amino acid sequence selected from the group consisting of SEQ ID NOs:
- 10 or 13, the heavy chain variable region has an amino acid sequence as set forth in SEQ ID NO:
- 11.
Dependencies are inferred from the claim text.